These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6963084)

  • 1. Treatment of murine myeloid leukemia by aclacinomycin-A based on the dynamics of leukemic colony forming unit and normal hematopoietic stem cells.
    Nara N
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1324-32. PubMed ID: 6963084
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of aclacinomycin-A on murine leukemia.
    Nara N; Miyamoto T; Hirashima K; Momoi H
    Blood; 1982 Jul; 60(1):188-93. PubMed ID: 6952948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on leukemic clonogenic cells in murine myeloid leukemia of 1-beta-D-arabinofuranosylcytosine and the anthracyclines adriamycin, daunomycin, aclacinomycin A, and 4'-epidoxorubicin.
    Nara N; Yamashita Y; Murohashi I; Tanikawa S; Imai Y; Aoki N
    Cancer Res; 1987 May; 47(9):2376-9. PubMed ID: 3471325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of recruitment-synchronization in the scheduling of 1-beta-D-arabinofuranosylcytosine in a slow-growing acute myeloid leukemia of the rat.
    Aglietta M; Colly L
    Cancer Res; 1979 Jul; 39(7 Pt 1):2727-32. PubMed ID: 286639
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia.
    Colly LP; Peters WG; Willemze R
    Cancer Res; 1986 Aug; 46(8):3825-7. PubMed ID: 3460691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combination therapy of specific active immunization and aclacinomycin-A on murine myeloid leukemia.
    Nara N; Jinnai I; Bessho M; Hirashima K
    Nihon Ketsueki Gakkai Zasshi; 1984 Sep; 47(6):1280-6. PubMed ID: 6595931
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J; Fehér I; Kovács P
    Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for leukemia stem cells--not yet the end of the road?
    Jordan CT
    Cancer Cell; 2006 Oct; 10(4):253-4. PubMed ID: 17045202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin responsiveness in vivo of Friend virus target cells for transformation and virus replication.
    Nasrallah AG; McGarry MP
    Cancer Res; 1978 Nov; 38(11 Pt 1):3774-8. PubMed ID: 698937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vesnarinone, a quinolinone derivative, on the growth of leukemic blasts in acute myelogenous leukemia.
    Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
    Exp Hematol; 1997 Mar; 25(3):199-204. PubMed ID: 9091294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man.
    Buick RN; Messner HA; Till JE; McCulloch EA
    J Natl Cancer Inst; 1979 Feb; 62(2):249-55. PubMed ID: 310906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.
    Huntly BJ; Shigematsu H; Deguchi K; Lee BH; Mizuno S; Duclos N; Rowan R; Amaral S; Curley D; Williams IR; Akashi K; Gilliland DG
    Cancer Cell; 2004 Dec; 6(6):587-96. PubMed ID: 15607963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inducers of cell differentiation in acute myeloid leukemias].
    Sánchez Fayos J
    Sangre (Barc); 1981; 26(5-A):619-25. PubMed ID: 6976644
    [No Abstract]   [Full Text] [Related]  

  • 14. [Colony-forming ability of bone marrow hematopoietic cells in mice with transplanted leukemia during administration of carminomycin].
    Kozinets GI; Ivanova LE; Khanykova OK; Kuznetsova TV; Rudneva NA
    Eksp Onkol; 1984; 6(5):59-62. PubMed ID: 6510345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maturation hierarchy of leukemic stem cells.
    Löwenberg B; Terpstra W
    Stem Cells; 1998; 16 Suppl 1():85-8; discussion 89. PubMed ID: 11012150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia.
    Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
    Exp Hematol; 1995 Aug; 23(9):1030-4. PubMed ID: 7543415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Culture studies in vitro in human leukemia.
    Spitzer G; Verma DS; Dicke KA; McCredie KB
    Semin Hematol; 1978 Oct; 15(4):352-78. PubMed ID: 366760
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nature of the target cells for Rauscher and Friend leukemia viruses].
    Sanin AV; Khorobrykh VV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1980; (8):5-20. PubMed ID: 6996749
    [No Abstract]   [Full Text] [Related]  

  • 19. WEHI-3B D+ Y1 leukemia cells as a model system to assess the induction of differentiation in vivo.
    Gamba-Vitalo C; Carman MD; Sartorelli AC
    Cancer Commun; 1989; 1(3):157-65. PubMed ID: 2561737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro sensitivity of leukemic clonogenic cells to four anthracyclines (adriamycin, daunorubicin, rubidazone and aclacinomycin) in human acute myeloid leukemia.
    Marie JP; Thevenin D; Zittoun R
    Nouv Rev Fr Hematol (1978); 1985; 27(3):163-7. PubMed ID: 3862071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.